References
- J. Immunol. v.130 Flow cytometric studies of oxidative product formation by neutrophils:a graded response to membrance stimulation Bass,D.A.;Parce,J.W.;Dechatelet,L.R.;Szejda,P.;Seeds.M.C.;Thomas,M.
- Proc. Natl. Acad. Sci. USA. v.80 A primate model of parkinsonism:selective destruction of dopaminergic neurons in the pars compacta of the substansia nigra by 1-methyl-4-pheny-1,2,3,6-tetrahydropyridine Burns,R.S.;Chiueh,C.C.;Markey,S.P.;Ebert,M.H.;Jacobwitz,D.M.;Kopin,I.J.
- Life. Sci. v.36 Potential bioactivaton pathways for the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP) Castagnoli,N.;Chiba,K.;Trevor,A.J.
- Biochem. Res. Commun. v.120 Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase Chiba,K.;Trevor,A.;Castagnoli,N.
- Eur. J. Pharmacol. v.119 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiochromate Corsini,GU.;Pintus,S.;Chiueh,C.C.;Weiss,J.F.;Kopin,I.J.
- Biochem. Biophys. Res. Commun. v.137 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)causes rapid ATP depletion in isolated hepatocytes di Monte,D.;Jewell,S.A.;Ekstrom,G.;Saandy,M.S.;Smith,T.P.
- Chem-Biol. Interactions v.62 Role of 1-methyl-4-phenylpyridinium ion formation and accumulation in 1-mehtyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity to isolated hepatocytes di Monte,D.;Ekstrom,G.;Shinka,T.;Smith,M.T.;Trevor,A.J.;Castagnoli,N.
- Eur. J. Pharmacol. v.97 Neurotoxicity of meperidine analogue MPTP in brain catecholamine neuron in the mouse Hallman,H.;Olson,L.;Jonsson,G.
- Neuropharmacol. v.23 Effect of MPTP on nigrostriatal dopamine in mice Heikkila,R.E.;Cabbot,R.A.;Manzino,L.;Duvoisin,R.C.
- Naure. v.311 Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidase inhibitors Heikkila,R.E.;Manzino,L.;Cabbat,F.S.;Duvoisin,R.C.
- Life. Sci. v.38 1-Methyl-4-phenylpyridine(MPP+) induces oxidative stress in the rodent Johannessen,J.N.;Adams,J.D.;Schuller,H.M.;Bacon,J.P.;Markey,S.P.
- Ann. Rev. Neurosci. v.11 MPTP toxicity:implications for research in Parkinson's disease Kopin,I.J.;Markey,S.P.
- Brain. Res. v.292 Selective nigral toxicity after systemic administration of 1-methyl-1,2,3,6-tetrahydropyridine(MPTP)in the squirrel monkey Langston,W.J.;Forno,L.S.;Rebert,C.S.;Irwin,I.
- Science v.225 Pargyline prevents MPTP-induced parkinsonism in primates Langston,W.J.;Irwin,I.;Langston,E.B.;Forno,L.S.
- Toxicol. Appl. Phamacol. v.104 Organometal-induced increases in oxygen reactive species: the potential fo 2'7'-dichlorofluorescin diacetate as ad index of neurotoxic damage Lebel,C.P.;Ali,S.F.;McKee,M.;Bondy,S.C.
- Science v.224 Trail of ironies to parkinson's disease Lewin,R.
- Life Sci. v.36 Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-1,2,3,6-tetra-hydropyridine Niklas,W.J.;Vyas,I.;Heikkila,R.E.
-
Biochem. Biophys. Res. Commun.
v.134
Uptake of the neurotoxin 1-methyl-4-phenylpyridine(
${MPP}^+$ )by mitochondria and its relation to the inhibiton of the mitochondrial oxidation of (${NAD}^+$ )-linked substrares by (${MPP}^+$ ) Ramsey,R.R.;Salach,J.I.;Singer,T.P. - Biochem. Pahrmacol. v.37 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP) and free radical in vitro Rosset,Z.L.;Sotgiu,A.;Sharp.D.E.;Hajiconstantinou,M.;Neff,N.H.
- Biochem. Pharmacol. v.31 Activation on pharmacologic agent to radical intermediates. Implications for the role of free radicals in drug action and toxicity Trush,M.A.;Mimnaugh,E.G.;Gram,T.E.
- J. Neurochem. v.46 Studies on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine:inhibition of NAD-linked substrate oxidation by its metabolite, 1-methyl-4-phenyl-pyridinium Vyas,I.;Heikilla,R.E.;Nicklas,W.J.